From: Evidence for the use of Levomepromazine for symptom control in the palliative care setting: a systematic review
Bioavailability
20-40% p.o.
Onset of action
30 min.
Maximum serum concentration (tmax)
p.o.: 2–3 h
i.m.: 30–60 min
Half life (t1/2)
15-30 h
Duration of action
8 h